Synthetic Drugs will soon be illegal in the state of North Dakota. As early as the end of November it will not only be a felony to SELL the synthetics, but also to have possession of them. Today Jon Berg attended an emergency meeting, where Attorney General Wayne Stenehjem is taking action to stop synthetics from circulating in North Dakota. On Wednesday we told you North Dakota Attorney General Wayne Stenehjem issued a cease and desist order to Big Willies in Mandan --- a store that sold the synthetic products. Thursday Stenehjem takes an additional step to stop synthetics from circulating in North Dakota --- meeting in front of the North Dakota Board of Pharmacy to add synthetic drugs to the same list as marijuana. "I reached the conclusion that we cannot wait, even three or four months until the session of the legislature comes in because, the lives and health of citizens in North Dakota and especially our young people are at stake," North Dakota Attorney General Wayne Stenehjem said. Under the list of controlled substances --- possession and sale of these products will be a felony once this rule takes effect --- Which Stenehjem thinks will happen by … Continue reading →

Published: 12:58PM Friday November 16, 2012 Source: BANG Showbiz Singer Jon Bon Jovi - Source: BANG Showbiz Drug charges against Jon Bon Jovi's teenage daughter are set to be dropped. Police were called after the Hamilton College student - whose father battled drug addiction in his youth - was found unresponsive in her dorm room in Kirkland, New York, but 19-year-old Stephanie Rose Bongiovi and the male who was with her won't face charges. According to gossip website TMZ, the District Attorney dropped all charges because of a "New York law that specifically prohibits prosecution of people experiencing a drug overdose -- as well as the people who help them seek medical care". A small bag of heroin along with marijuana and other drug paraphernalia were reportedly discovered in Bongiovi's room. Her troubles come shortly after Bon Jovi was forced to cut short his UK publicity tour and boarded a private jet to return to his wife and children after their $US24 million home was badly damaged by Hurricane Sandy leaving them stranded without power. A source close to the 50-year-old singer said: "He was really incredibly anxious for his family who were stuck in New York in an apartment … Continue reading →

CANCER patients are being given expensive drugs that extend their lives by just a few months or provide no benefit, risking a health budget blow-out. Cancer researcher Deme Karikios said the total cost to the federal government of subsidising cancer drugs had risen from $65 million to more than $500 million in the decade to 2010. "We are seeing some drugs approved that extend median survival by only a few months, yet they add hundreds of millions of dollars to health system costs,'' Dr Karikios, from the University of Sydney, said. ''Many are asking whether that money could be better spent." Much of the increase was due to the ''explosion'' of new cancer drugs in recent years. Advertisement Dr Karikios' research, conducted through the National Health and Medical Research Council Clinical Trials Centre, found the average cost of a newly listed cancer drug through the Pharmaceutical Benefits Scheme in 2010 was $5000 per month. ''We need to rethink how drugs are approved in Australia, or hard decisions may need to be made in future about which drugs patients can access.'' It was important for researchers and clinicians to identify those patients for whom new treatments would be effective, Dr Karikios … Continue reading →

15 November 2012 Last updated at 19:02 ET By James Melik Reporter, Business Daily, BBC World Service The US states of Washington and Colorado have voted to legalise the possession and sale of marijuana for recreational purposes, in defiance of federal law, setting the stage for a potential showdown with President Barack Obama's administration. However, it reawakens the debate about whether banned drugs should go on sale legally. Not only could such a move potentially open up a huge commercial market, but it could also become a source of tax revenue. But it is an extremely controversial issue and even in the Netherlands, which led the way with its cannabis cafes, the policy is now being questioned. In the Netherlands, marijuana is not formally legal, but it can be sold in small quantities in licensed coffee shops. In one such coffee shop, on a houseboat on the river Maas in the southern Dutch town of Maastricht, Stephan explains there are about 5,000 varieties of marijuana, or cannabis, in the world. You can never win a war against drugs, you can only control it by being realistic and pragmatic "We sell white rhino, silver haze, amnesia, lemon haze. We sell blue … Continue reading →

Projected launch of disease-modifying drugs to set new industry standards LONDON, Nov. 14, 2012 /PRNewswire/ -- The patent expiry of all four existing EMEA approved drugs for Alzheimer's disease (AD) by 2015 is likely to cause a steep decline in the growth of the European AD medication market. However, the approval of next generation therapies that can delay disease progression and restore cognitive functions are expected to revive opportunities in the market from 2015 to 2018. New analysis from Frost & Sullivan ( http://www.healthcare.frost.com( http://www.frost.com/prod/servlet/svcg.pag/HCLS )), European Alzheimer's Disease Medication Market, estimates the market to earn US$1.80 billion in 2012 and reach US$4.78 billion in 2019, growing at a compound annual growth rate (CAGR) of 15.1% from 2012-2019. "Increasing R&D activity and a strong pipeline of disease modifying drugs bode well for market expansion," notes Frost & Sullivan Senior Research Analyst Aiswariya Chidambaram. "Considerable unexplored opportunities and the commercial goldmine that is the AD medication market have motivated several pharmaceutical and biotechnology companies to invest in R&D, particularly targeting the moderate-to-severe patient group." Existing drug classes for AD offer poor therapeutic efficacy. The core focus of new R&D approaches has therefore centered on novel disease modifying drugs. "These drugs are … Continue reading →

NEW YORK, Nov. 14, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Diabetes Drugs Market 2011-2015 http://www.reportlinker.com/p01027189/Global-Diabetes-Drugs-Market-2011-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication TechNavio's analysts forecast the Global Diabetes Drugs market to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Diabetes Drugs market has also been witnessing the trend of increasing awareness and education. However, the increasing use of complementary and alternative medicine (CAM) could pose a challenge to the growth of this market. TechNavio's report, the Global Diabetes Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Diabetes Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space include Eli Lilly and Co., Merck and Co. Inc., Novo Nordisk A/S and Sanofi S.A. See the article here: Global Diabetes Drugs Market 2011-2015 … Continue reading →